It’s being called a landmark cancer vaccine and it’s got scientists very ‘excited’
Full story
A phase 3 international trial for a cancer vaccine involved 1137 participants. These individuals had high-risk melanoma that was previously removed through surgery. Scientists have expressed excitement over the results of this landmark study.
The international phase 3 trial involved 1137 people whose high-risk melanoma had been surgically removed.